Labcorp to Speak at the Baird 2024 Global Healthcare Conference
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
BURLINGTON, N.C., Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, at 3:10 p.m. ET.
全球领先的创新型和综合性实验室服务提供商Labcorp（纽交所：LH）今天宣布，公司的高管团队成员将参加贝尔德2024全球医疗保健大会，演讲时间为9月10日下午3:10（Eastern Time）.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA and performed more than 600 million tests for patients around the world. Learn more about us at .
关于Labcorp
Labcorp（纽交所：LH）是一家全球领先的创新型和综合性实验室服务提供商，帮助医生、医院、药品公司、研究人员和患者做出明确和自信的决策。我们通过独一无二的诊断和药物研发实验室能力，提供洞察力并推动科学进步，改善健康并提高生活质量。该公司的逾67,000名员工为约100个国家的客户提供服务，为美国食品药品监督管理局在2023年批准的84%新药和治疗产品提供支持，并为全球患者进行了逾60000万个测试。了解更多信息，请访问网站。
SOURCE Labcorp Holdings Inc
Labcorp Holdings Inc的消息来源